ChimeriVax-West Nile vaccine - PubMed (original) (raw)

Affiliations

Review

ChimeriVax-West Nile vaccine

Roy A Hall et al. Curr Opin Mol Ther. 2007 Oct.

Abstract

Acambis (formerly Peptide Therapeutics) is developing ChimeriVax-West Nile, a recombinant live-attenuated vaccine which incorporates their ChimeriVax platform technology, for the potential prevention of West Nile virus infection [373463], [328969]. A phase II clinical trial to assess the safety, tolerability and immunogenicity of different doses of ChimeriVax-West Nile is underway [642090], [775386].

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources